Page 89 - MEMORIA ANUAL 2019 SEHH-FEHH
P. 89
MEMORIA ANUAL 2019
SOCIEDAD ESPAÑOLA FUNDACIÓN ESPAÑOLA
DE HEMATOLOGÍA Y HEMOTERAPIA DE HEMATOLOGÍA Y HEMOTERAPIA
F, Arnao-Herráiz M, Rodríguez I, Llopis-Calatayud I, Jiménez MJ, Del Cañizo-Roldán MC, Díez-Campelo M. Hidden myelodysplastic syndrome (MDS): a prospective study to confirm or exclude MDS in patients with anemia of uncertain etiology. Int J Lab Hematol. 2019 Feb;41(1):109-17. doi: 10.1111/ijlh.12933.
• Palomo L, Ibáñez M, Abáigar M, Vázquez I, Álvarez S, Cabezón M, Tazón-Vega B, Rapado I, Fuster-Tormo F, Cervera J, Benito R, Larrayoz MJ, Cigudosa JC, Zamora L, Valcárcel D, Cedena MT, Acha P, Hernández-Sánchez JM, Fernández-Mercado M, Sanz G, Hernández-Rivas JM, Calasanz MJ, Solé F, Such E; Spanish Group of MDS (gEsmd). Spanish Guidelines for the use of targeted deep sequencing in myelo- dysplastic syndromes and chronic myelomonocytic leukaemia. Br J Haematol. 2020 Mar;188(5):605-22. doi: 10.1111/bjh.16175.
• Montes P, Bernal M, Campo LN, González Ramírez AR, Jiménez P, Garrido P, Jurado M, Garrido F, Ruiz-Cabello F, Hernández F. Tumor genetic alterations and features of the immune microenvironment drive myelodysplastic syndrome escape and progression. Cancer Immunol Immunother. 2019 Dec;68(12):2015-27. doi: 10.1007/ s00262-019-02420-x.
• Florensa L, Arenillas L, Calvo X, Pérez-Vila E, Montesdeoca S, Ferrer A, Woessner S. The importance of adequate recognition of normal and dysplastic myelopoiesis for the diagnosis of myelodysplastic syndromes. Histol Histopathol. 2019;34:857- 73. doi: 10.14670/HH-18-093.
Presentaciones orales en congresos internacionales
• 15th International Symposium on Myelodysplastic Syndromes. Copenhagen, 2019:
– Palomo L, Meggendorfer M, Hutter S, Twardziok S, Ademà V, Fuhrmann I, Fuster- Tormo F, Acha P, Solé F, Haferlach C, Haferlach T. Molecular characterization and clonal architecture of adult MDS/MPN.
– Bernard E, Nannya Y, Yoshizato T, Hasserjian RP, Saiki R, Shiozawa Y, Devlin SM, Tuechler H, Sarian A, Malcovati L, Solé F, Haase D, Creignou M, Levine M, Germing U, Cargo C, Zhang Y, Medina J, Arango Ossa JE, Schanz J, Van De Loosdrecht A, Jädersten M, Bennett JM, Tobiasson M, Kosmider O, Follo MY, Thol F, Pinheiro RF, Santini V, Kotsianidis I, Boultwood J, Santos FP, Kasahara S, Ishikawa T, Tsurumi H, Takaori-Kondo A, Kiguchi T, Polprasert C, Klimek VM, Savona MR, Belickova M,
GRUPO ESPAñOL DE SÍNDROMES MIELODISPLÁSICOS (GESMD)
89
